Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use METADATE CD® safely and effectively. See full prescribing information for METADATE CD. METADATE CD (methylphenidate hydrochloride) extended-release capsules, CII Initial U.S. Approval: 1955
Medication labelWhy this: Advisory · dailymed-prescription
METADATE CD is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in pediatric patients 6 to 15 years of age. Limitations of Use The use of METADATE CD is not recommended in pediatric patients younger than 6 years of age because they had higher plasma exposure and a higher incidence of adverse reactions (e.g. weight loss) than patients 6 years and older at the same dosage [see Warnings and Precautions (5.7), Use in Specific Populations (8.4)].
- generic_name
- methylphenidate hydrochloride
- product_names
- methylphenidate hydrochloride
- ndc
- 0527-6579, 0527-6579-30, 0527-6580, 0527-6580-30, 0527-6581, 0527-6581-30, 0527-6582, 0527-6582-30, 0527-6583, 0527-6583-30, 0527-6584, 0527-6584-30
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en